What are the current anti-COVID-19 drugs? From traditional to smart molecular mechanisms
Abstract Background Coronavirus disease 19 (COVID-19) is the disease caused by SARS-
CoV-2, a highly infectious member of the coronavirus family, which emerged in December …
CoV-2, a highly infectious member of the coronavirus family, which emerged in December …
A systematic review on SARS‐CoV‐2‐associated fungal coinfections
S Soni, R Namdeo Pudake, U Jain… - Journal of medical …, 2022 - Wiley Online Library
A severe pandemic of Coronavirus Disease (COVID‐19) has been sweeping the globe
since 2019, and this time, it did not stop, with frequent mutations transforming into virulent …
since 2019, and this time, it did not stop, with frequent mutations transforming into virulent …
Species diversity, updated classification and divergence times of the phylum Mucoromycota
H Zhao, Y Nie, TK Zong, K Wang, ML Lv, YJ Cui… - Fungal Diversity, 2023 - Springer
Zygomycetes are phylogenetically early diverging, ecologically diverse, industrially
valuable, agriculturally beneficial, and clinically pathogenic fungi. Although new phyla and …
valuable, agriculturally beneficial, and clinically pathogenic fungi. Although new phyla and …
Potential inhibitory activity of phytoconstituents against black fungus: In silico ADMET, molecular docking and MD simulation studies
Mucormycosis or “black fungus” has been currently observed in India, as a secondary
infection in COVID-19 infected patients in the post-COVID-stage. Fungus is an uncommon …
infection in COVID-19 infected patients in the post-COVID-stage. Fungus is an uncommon …
[HTML][HTML] Mucormycosis and COVID-19 pandemic: Clinical and diagnostic approach
The pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is
yet to be controlled worldwide, especially in India. The second wave of coronavirus disease …
yet to be controlled worldwide, especially in India. The second wave of coronavirus disease …
[HTML][HTML] COVID-19-associated mucormycosis: an opportunistic fungal infection. A case series and review
A Al Balushi, A Al Ajmi, Q Al Sinani, V Menon… - International Journal of …, 2022 - Elsevier
Background A surge in COVID-19-associated mucormycosis cases has been observed
during the second wave of COVID-19 in summer of 2021. Most cases were reported from …
during the second wave of COVID-19 in summer of 2021. Most cases were reported from …
[HTML][HTML] Mucormycosis an added burden to Covid-19 Patients: An in-depth systematic review
NN Shah, Z Khan, H Ahad, AY Elderdery… - Journal of infection and …, 2022 - Elsevier
Abstract As of 25th July, 2022, global Disease burden of 575,430,244 confirmed cases and
over 6,403,511 deaths have been attributed to coronavirus disease 2019 (COVID-19). Co …
over 6,403,511 deaths have been attributed to coronavirus disease 2019 (COVID-19). Co …
COVID-19-associated mucormycosis: a matter of concern amid the SARS-CoV-2 pandemic
P Chandley, P Subba, S Rohatgi - Vaccines, 2022 - mdpi.com
Mucormycosis is an invasive fungal infection caused by fungi belonging to order Mucorales.
Recently, with the increase in COVID-19 infections, mucormycosis infections have become a …
Recently, with the increase in COVID-19 infections, mucormycosis infections have become a …
Management of invasive infections in diabetes mellitus: A comprehensive review
Patients with diabetes often have more invasive infections, which may lead to an increase in
morbidity. The hyperglycaemic environment promotes immune dysfunction (such as the …
morbidity. The hyperglycaemic environment promotes immune dysfunction (such as the …
Update on overview of ocular manifestations of COVID-19
M Akbari, M Dourandeesh - Frontiers in medicine, 2022 - frontiersin.org
The coronavirus disease 2019 (COVID-19) has become the most critical health crisis at
present, and research is continued about the exact pathophysiology, presentations, and …
present, and research is continued about the exact pathophysiology, presentations, and …